Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,823 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,089 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00636545 | Genasense as a 2-hour Intravenous Infusion in Subjects With Solid Tumors | completed | Phase 1 | 25 | Genta IncorporatedINDUSTRY | 1 | Apr 6, 2012 | clinicaltrials |
| NCT00307255 | Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine in Treating Patients With Advanced Metastatic Solid Tumors | completed | Phase 1 | 18 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Apr 4, 2012 | clinicaltrials |
| NCT00949559 | Pharmacodynamics (PD) and Pharmacokinetics (PK) Study of EP-100 in Advanced Solid Tumors | completed | Phase 1 | 38 | Esperance Pharmaceuticals IncINDUSTRY | 1 | Apr 4, 2012 | clinicaltrials |
| NCT00253474 | PEG-Interferon Alfa-2b in Treating Young Patients With Plexiform Neurofibroma | completed | Phase 1 | 36 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 29, 2012 | clinicaltrials |
| NCT00703378 | Target Dosing of Docetaxel Through Pharmacokinetic/Pharmacodynamic Optimisation of the First Chemotherapeutic Cycle | completed | Phase 1 / Phase 2 | 33 | National University Hospital, SingaporeOTHER | 1 | Mar 28, 2012 | clinicaltrials |
| NCT00804310 | Lapatinib and Ixabepilone in Treating Patients With Advanced Solid Tumors(UCDCC#207) | terminated | Phase 1 | 5 | University of California, DavisOTHER | 1 | Mar 28, 2012 | clinicaltrials |
| NCT01072890 | Temsirolimus and Pazopanib in Patients With Advanced Solid Tumors | completed | Phase 1 | 8 | University of California, DavisOTHER | 1 | Mar 28, 2012 | clinicaltrials |
| NCT01469052 | First In Human, Phase 1 Study of AG013736 In Patients With Solid Tumors | completed | Phase 1 | 36 | PfizerINDUSTRY | 1 | Mar 26, 2012 | clinicaltrials |
| NCT00019513 | Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas | completed | Phase 1 | 108 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 23, 2012 | clinicaltrials |
| NCT01381341 | To Compare Relative Bioavailability of Two Clinical Formulations of Linifanib. | completed | Phase 1 | 13 | AbbottINDUSTRY | 1 | Mar 23, 2012 | clinicaltrials |
| NCT00253461 | 11C Topotecan PET Imaging | terminated | Early Phase 1 | 7 | Case Comprehensive Cancer CenterOTHER | 1 | Mar 20, 2012 | clinicaltrials |
| NCT00402935 | Ovarian Damage in Young Premenopausal Women Undergoing Chemotherapy for Cancer | withdrawn | — | 0 | Case Comprehensive Cancer CenterOTHER | 1 | Mar 20, 2012 | clinicaltrials |
| NCT00054223 | Study of Decision Making in Patients Participating in Phase I Clinical Trials | completed | N/A | 250 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 16, 2012 | clinicaltrials |
| NCT00734890 | Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma | completed | Phase 1 | 18 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 16, 2012 | clinicaltrials |
| NCT00019019 | Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas | completed | Phase 1 | 70 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00030108 | Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy | completed | Phase 1 | 30 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00031941 | CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy | completed | Phase 1 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00036959 | ABT-751 in Treating Young Patients With Refractory Solid Tumors | completed | Phase 1 | 90 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00043030 | Evaluating Patient Participation in Phase I Clinical Trials | completed | N/A | 120 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00088868 | 17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma | completed | Phase 1 | 40 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00095914 | Paclitaxel and ABI-007 in Treating Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00303940 | Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors | completed | Phase 1 | 26 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00356980 | TNF-Bound Colloidal Gold in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 60 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00387608 | ABT-888 in Patients With Refractory Solid Tumors or Hematologic Cancer | completed | Phase 1 | 23 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00899691 | Study of Hair Samples From Patients With Cancer | completed | — | 190 | National Institutes of Health Clinical Center (CC)NIH | 0 | Mar 15, 2012 | clinicaltrials |
| NCT01337310 | Study of Tesetaxel in Japanese Patients With Solid Tumors | unknown | Phase 1 | 12 | Genta IncorporatedINDUSTRY | 1 | Mar 13, 2012 | clinicaltrials |
| NCT00737191 | Opioids With or Without Olanzapine in Treating Patients With Moderate to Severe Cancer Pain | withdrawn | N/A | 0 | Mayo ClinicOTHER | 0 | Mar 9, 2012 | clinicaltrials |
| NCT00908908 | A Study to Determine the Metabolism and Elimination of Carbon-14 Labeled Eribulin Acetate (14C-Eribulin) in Patients With Advanced Solid Tumors | completed | Phase 1 | 6 | Eisai Inc.INDUSTRY | 1 | Mar 9, 2012 | clinicaltrials |
| NCT00021047 | Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor | completed | Phase 1 / Phase 2 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00062049 | Interleukin-7 in Treating Patients With Refractory Solid Tumors | completed | Phase 1 | 30 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00079469 | Bupropion and Counseling With or Without Contingency Management to Enhance Smoking Cessation in Treating Cancer Survivors Who Continue to Smoke | completed | N/A | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00559039 | Effects of Fetal, Infant, and Early Childhood Exposures on Adult Cancer Risk in Women | completed | — | 128,700 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00589381 | Fenretinide Lym-X-Sorb™ in Treating Patients With Recurrent or Resistant Solid Tumors or Lymphoma | completed | Phase 1 | 30 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00520000 | Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Metastatic Solid Tumors | completed | Phase 1 | 47 | UNC Lineberger Comprehensive Cancer CenterOTHER | 0 | Mar 6, 2012 | clinicaltrials |
| NCT00606814 | Phase I Study of IPI-504 and Docetaxel in Patients With Advanced Solid Tumors | completed | Phase 1 | 60 | Infinity Pharmaceuticals, Inc.INDUSTRY | 1 | Mar 6, 2012 | clinicaltrials |
| NCT00469937 | Ph I Study of Lithium During Whole Brain Radiotherapy For Patients With Brain Metastases | terminated | Phase 1 | 9 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Feb 28, 2012 | clinicaltrials |
| NCT01212887 | Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer | terminated | Phase 1 | 14 | Cancer Research UKOTHER | 1 | Feb 28, 2012 | clinicaltrials |
| NCT01096381 | Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor | terminated | — | 8 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Feb 27, 2012 | clinicaltrials |
| NCT01046461 | Ramosetron, Aprepitant and Dexamethasone (RAD) in Solid Cancer(RAD) | unknown | Phase 2 | 41 | Hallym University Medical CenterOTHER | 1 | Feb 17, 2012 | clinicaltrials |
| NCT00737555 | A Study of the Safety and Tolerability of the Addition of CHR-2797 to Paclitaxel in Patients With Advanced or Refractory Tumours | completed | Phase 1 | 23 | Chroma TherapeuticsINDUSTRY | 1 | Feb 15, 2012 | clinicaltrials |
| NCT00661414 | Safety Study of ASONEP (Sonepcizumab/LT1009) to Treat Advanced Solid Tumors(ASONEP) | completed | Phase 1 | 37 | Lpath, Inc.INDUSTRY | 1 | Jan 31, 2012 | clinicaltrials |
| NCT00949624 | CP-868,596 And CP-868,596 Plus AG-013736 In Combination With Docetaxel In Advanced Solid Tumors | completed | Phase 1 | 50 | Arog Pharmaceuticals, Inc.INDUSTRY | 2 | Jan 19, 2012 | clinicaltrials |
| NCT00296062 | Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal Cancer | terminated | Phase 1 | 12 | Case Comprehensive Cancer CenterOTHER | 1 | Jan 16, 2012 | clinicaltrials |
| NCT01509300 | HLA-haploidentical Hematopoietic Stem Cell Transplantation for Children and Adolescents With Acute Leukemia, Myelodysplastic Syndrome and Solid Tumors | unknown | Phase 1 / Phase 2 | 10 | Asan Medical CenterOTHER | 1 | Jan 13, 2012 | clinicaltrials |
| NCT01028859 | Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers | completed | Phase 1 | 30 | Chong Kun Dang PharmaceuticalINDUSTRY | 1 | Dec 22, 2011 | clinicaltrials |
| NCT00069264 | Study of E7389 in Patients With Advanced Solid Tumors | completed | Phase 1 | 33 | Eisai Inc.INDUSTRY | 1 | Dec 20, 2011 | clinicaltrials |
| NCT01491204 | Clinical Trial to Determine the Maximum Tolerated Dose and to Assess the Safety and Pharmacokinetic Profile of Oral Paclitaxel in Patients With Advanced Solid Cancer | completed | Phase 1 | 25 | Hanmi Pharmaceutical Company LimitedINDUSTRY | 0 | Dec 13, 2011 | clinicaltrials |
| NCT00935844 | Study of TAK-901 in Adults With Advanced Solid Tumors or Lymphoma | completed | Phase 1 | 20 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 8, 2011 | clinicaltrials |
| NCT00831896 | Phase I Study of TAK-701 in Adult Patients With Advanced Nonhematological Malignancies | completed | Phase 1 | 27 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 2, 2011 | clinicaltrials |
| NCT00697879 | Safety Study of the Histone Deacetylase Inhibitor, CHR-3996, in Patients With Advanced Solid Tumours | completed | Phase 1 | 40 | Chroma TherapeuticsINDUSTRY | 2 | Nov 28, 2011 | clinicaltrials |
Data updated 23 days agoSource updated Apr 6, 2012source: clinicaltrials